De-Risking the Future of Texas Healthcare: CPRIT’s $103 Million Catalyst & Texas’s Growing Data Center Moratoriums Shape Health Tech.
June 2026 | Vol. 1, Issue 2
Mapping the intersection of medicine and venture capital across the Texas Triangle.
Executive Summary
As Google’s monumental $40 billion artificial intelligence infrastructure blueprint actively materializes across the state, a mounting clash over local resource consumption has reached a historic boiling point. Headlined by Hill County enacting Texas’s first-ever rural data center construction moratorium, and the immediate, high-stakes $100 million federal lawsuit filed by developers in retaliation, the state has become a fierce battleground over the physical constraints of AI compute.
Against this backdrop of infrastructure friction, a massive $103 million state injection from CPRIT fueling local oncology and clinical trial innovation, Texas’s healthcare venture market is surging with clinical depth. Beneath these massive headlines, a wave of momentum is sweeping the state, powered by dynamic Seed, Series A, and Series B rounds from pioneering Texas startups, like Secretome Therapeutics’ $30 million Series A.
Macro Signals
CPRIT approving $103 million across 69 new innovation grants
The Cancer Prevention and Research Institute of Texas (CPRIT) approved $103 million across 69 new innovation grants highlighting a critical structural advantage of the Texas life sciences market: sovereign de-risking.
The Signal: At a time when macroeconomic pressures have compressed traditional VC fund timelines, Texas is leveraging state-backed, non-dilutive capital to absorb the early, highest-risk phases of clinical R&D. By funding infrastructure, next-gen scientist recruitment, and specifically expanding clinical trial readiness into underserved and rural regions (via new Rural Clinical Trial Accelerator awards), the state is essentially building a taxpayer-subsidized staging ground. For private venture funds, this serves as a massive force multiplier. It means early-stage Texas startups can achieve critical human clinical data and operational validation before they ever have to pitch a VC for a Series A, drastically reducing investment risk and preserving founder equity.
Google's $40 billion infrastructure investment v. Hill County’s Moratorium
While billions in corporate capital continue to target the state, May 2026 marked the arrival of structural friction. Hill County made national headlines by voting 3–2 to enact a historic one-year moratorium on data center construction in its unincorporated areas. This marks the first Texas county to successfully implement a development freeze in response to dropping water tables and massive grid strain.
The Signal: This localized pushback—combined with Texas Agriculture Commissioner Sid Miller subsequently calling for a temporary statewide pause on hyperscale data centers—signals a critical shift for digital biology and AI investors. The primary bottleneck for scaling advanced compute in Texas is no longer a lack of capital or tax incentives; it is the raw physical constraint of power, water, and local zoning autonomy. For VCs backing energy-tech, smart-grid, and water-cooling innovations, this infrastructure friction represents a massive, highly immediate addressable market.
Secretome's $30 million Series A
Nationwide healthcare venture capital has shifted significantly from defense to high-conviction deployment.
The Signal: While total funding has rebounded from previous years, investors are strictly avoiding "speculative" software. Instead, they are concentrating capital into heavily vetted, asset-rich clinical plays. Secretome's $30 million Series A—backed entirely by an elite life-sciences fund like RA Capital—is a textbook example of this trend: massive checks are only flowing to companies with undeniable clinical validation and hard proprietary data.
UT Austin Taps Inaugural Chief of Translational AI
On May 18, 2026 Dell Medical School officially appointed Dr. Hongfang Liu as the inaugural chair of the newly established Department of Quantitative and Systems Health Sciences, concurrently filling the Carolyn and Kenneth Shine Endowed Chair in Artificial Intelligence as Chief Translational AI and Informatics Officer.
The Signal: For healthcare venture investors, this appointment signals that Texas's major academic pipelines are moving past the theoretical phase of healthcare AI. Dr. Liu, recruited from prior institutional AI leadership roles at Mayo Clinic and UTHealth Houston, specializes in translating large-scale real-world data and open-source clinical natural language processing (NLP) architectures into live, hospital-wide operations.
May Deal Tracker
| Company | Hub | Stage | Deal Value | Lead / Notable News |
|---|---|---|---|---|
| Secretome Therapeutics | Plano (DFW) | Series A | $30.0M | RA Captial Management (sole investor). Capital will advance their neonateal cardiac progenitor cell therapy into Phase 2/3 trials for rare disease cardiomyopathies |
| CPRIT Innovation Grants | Statewide | Grant funding | $103.0M | State-backed non-dilutive capital injection. Includes funding for clinical trial infastructure in rural regions and a notable $250,000 breast cancer imaging award to TCU |
| TensorLinks | Austin | Seed/Early | Undisclosed | Highlighted at the Health Supernova 2026 conference in Austin; scaling their voice-AI dental and healthcare front-office automation platforme |
| Prana Surgical | Houston | Seed/Grant | Undisclosed | Successfully completed first clinical procedures using its tissue-conserving Prana System for minimally invasive surgery |
Seed & Early Stage Rounds
SurgeReady Health (Dallas / Health Wildcatters) – Pre-Seed / Hackathon Winner
Crowned First Place winner at the 8th Annual Texas Healthcare Challenge Hackathon hosted at Pegasus Park. SurgeReady is building an AI-driven platform tailored specifically for surgical preparedness and perioperative coordination, heavily backed by Texas Health Resources' operational mentors.
Promptly (Dallas / Health Wildcatters) – Pre-Seed / Hackathon Winner
Captured the top spot in the MedTech Track (powered by Protoboard by Delta Robotics). Promptly is scaling an intelligent, real-time patient-provider communication platform designed to minimize post-discharge administrative friction.
OncoSwab (Houston / TMCi Pipeline) – Pre-Seed Translational
Emerging from the deep oncology ecosystem at the Texas Medical Center, OncoSwab hit a vital regulatory milestone by releasing its Research Use Only (RUO) nasal sampling device. The tech allows multi-site clinical trials to capture lung cancer biomarkers via a non-invasive nasal swab, bypassing standard blood draws or tissue biopsies.
HemePro Therapeutics (Dallas / UT Dallas Spinout) – Pre-Seed / Academic Pipeline
Officially advanced its pre-clinical testing pipeline out of the UT Dallas structural biology and chemistry divisions. HemePro represents the exact type of "asset-rich, hard-science" therapeutic plays that North Texas VCs are prioritizing over pure healthcare software.
TensorLinks (Austin) – Seed (Undisclosed Value)
Emerged as a major standout at Austin’s Health Supernova 2026 conference. TensorLinks is scaling a domain-specific voice-AI platform tailored explicitly for dental and specialist medical front-office operations, tackling severe administrative staffing shortages.
Prana Surgical (Houston) – Seed / Grant Extension (Undisclosed Milestone) *
A high-momentum Houston medtech play that hit a major milestone this month, successfully executing its first in-human clinical procedures using its proprietary Prana System™—a specialized tool enabling tissue-conserving, minimally invasive surgeries.
Texas Christian University / TCU Research (Fort Worth) – $250K Seed-Equivalent State Grant *
Selected as part of the broader May CPRIT tranche, this focused seed capital is backing the development of next-generation, high-resolution breast cancer imaging modalities emerging out of North Texas academic labs.
Series A Rounds
Secretome Therapeutics (Plano / DFW) – $30M Series A *
The undisputed heavyweight early-stage deal of the month. Backed solely by elite institutional life-sciences fund RA Capital Management, this massive round will push Secretome's STM-01—an allogeneic cell therapy derived from neonatal cardiac progenitor cells—directly into Phase 2/3 clinical trials for Duchenne muscular dystrophy-associated cardiomyopathy.
MassChallenge Healthcare Traction Cohort (Dallas / Statewide Hub) – Series A Accelerants *
Mid-May marked the intensive live phase of the 2026 MassChallenge Healthcare track running out of Dallas. A curated group of late-Seed and early-Series A startups in digital health and precision diagnostics finalized localized trial partnerships with North Texas hospital networks to lock down clinical validation metrics.
Series B Rounds
Enhabit Home Health & Hospice (Dallas) – Major Take-Private Acquisition / Exit
In one of the largest Texas healthcare private equity moves of the month, Dallas-based home health giant Enhabit officially ceased trading on the NYSE and went completely private after being acquired by Kinderhook Industries. For the North Texas venture world, this take-private exit underscores a massive macro shift: private equity is aggressively buying up established Texas healthcare networks to re-engineer their software, operational tech, and care delivery layer away from public market scrutiny.
Heritage Imaging (Dallas Hub) – Growth Private Equity Acquisition / Exit
Lower-middle-market private equity powerhouse Align Capital Partners (ACP) announced its platform acquisition of Heritage Imaging. Heritage operates an expansive, multi-state mobile diagnostic imaging network specializing in bringing high-tech PET/CT, MRI, and ultrasound modalities to underserved and critical-access rural hospitals. ACP plans to use its Dallas footprint to heavily finance add-on M&A, scaling the company's tech-enabled route infrastructure.
Upcoming Events
Texas Health Informatics Alliance (THIA) Sixth Annual Conference
When / Where: September 18, 2026 | UT Arlington / DFW Regional Hub
Information: Co-hosted by a massive coalition of Texas medical schools (including UTHealth Houston, UTSW, and UNT), the theme is “From Innovation to Impact: Implementing Trustworthy Health Informatics Across Texas.” This event is a hotspot for VCs evaluating B2B hospital infrastructure, clinical AI governance, digital twins, and simulated health tracking.
Link: View agenda tracks and deadlines at the official THIA 2026 Conference Site.
2026 iC³ Life Science & Healthcare Innovation Summit
When / Where: September 24–25, 2026 | Loews Arlington Hotel & Convention Center
Information: Hosted by BioNTX, this is the premier annual life sciences summit in North Texas. It functions as a heavy networking zone for institutional lifetech VCs, pharma business development execs, and later-stage startups hunting for Series A and B tranches.
Link: Register directly at the BioNTX iC³ Summit Registration Page.
The 2026 Healthcare Innovation Summit – Houston
When / Where: October 15, 2026 | Intercontinental Houston
Information: A highly targeted buyer-and-seller summit connecting C-level healthcare executives and hospital decision-makers with the enterprise healthtech startup ecosystem. Startups attend this to lock down the exact pilot agreements and provider ROIs that private VCs are demanding right now.
Link: Claim passes on the Healthcare Innovation Summit Houston Hub.
MedCity INVEST Digital Health 2026
When / Where: October 29, 2026 | Pegasus Park (Dallas)
Information: One of the premier nationwide digital health investment conferences stops right in the heart of Texas's core biotech park. Expect heavy participation from national corporate venture capital (CVC) funds, active angel networks, and early-stage pitch tracks.
Link: Register or view the pitch tracks on the MedCity INVEST Digital Health Landing Page.
Sources
Cancer Prevention and Research Institute of Texas. "CPRIT Awards More Than $103 Million in Cancer Grants; Expands Rural Clinical Trials." Cancer Prevention and Research Institute of Texas, 20 May 2026, cprit.texas.gov/news-events/articles/cprit-awards-more-than-103-million-in-cancer-grants-expands-rural-clinical-trials/. Accessed 1 June 2026.
Secretome Therapeutics. "Secretome Therapeutics Announces $30 Million Series A Financing From RA Capital Management to Advance STM-01 for Duchenne-Associated Cardiomyopathy." Business Wire, 27 May 2026, www.businesswire.com/news/home/20260527439636/en/. Accessed 1 June 2026.
Kinderhook Industries. "Enhabit Completes Previously Announced Acquisition by Kinderhook Industries to Become a Private Company." Kinderhook Industries Press Releases, 15 May 2026, www.kinderhook.com/press-releases/enhabit-completes-acquisition/. Accessed 1 June 2026.
Seeley, David. "Align Capital Partners Acquires Idaho-Based Heritage Imaging." Dallas Innovates, 28 May 2026, dallasinnovates.com/align-capital-partners-acquires-idaho-based-heritage-imaging/. Accessed 1 June 2026.
Texas Medical Center Innovation. "TMC Innovation Factory Accelerator Updates." Texas Medical Center, May 2026, tmc.edu/innovation/. Accessed 1 June 2026.
Health Wildcatters. "Texas Healthcare Challenge and Regional Accelerator Portals." Health Wildcatters, May 2026, www.healthwildcatters.com/events. Accessed 1 June 2026.
Engelland, Sandra. "Meet the Winners of Health Wildcatters' 2026 Texas Healthcare Challenge Hackathon." Dallas Innovates, 30 Apr. 2026, dallasinnovates.com/meet-the-winners-of-health-wildcatters-2026-texas-healthcare-challenge-hackathon/. Accessed 1 June 2026.
University of Texas at Dallas. "Researcher's Cancer-Fighting Drug Up for FDA Approval: HemePro Therapeutics Portfolio." School of Natural Sciences and Mathematics, May 2026, nsm.utdallas.edu/researchers-cancer-fighting-drug-up-for-fda-approval/. Accessed 1 June 2026.
TensorLinks. "TensorLinks at Health Supernova 2026: Austin's Premier Health Tech Event." TensorLinks Press & Conferences, May 2026, www.tensorlinks.com/conferences/health-supernova-austin-2026/. Accessed 1 June 2026.
Prana Surgical. "Prana Surgical Announces Milestone First-in-Human Clinical Procedures Using Prana System™." Business Wire, 12 May 2026, www.businesswire.com/news/home/20260512543912/en/. Accessed 1 June 2026.
MassChallenge. "MassChallenge Texas Healthcare Track and Cohort Progression Announcements." MassChallenge Program Portals, May 2026, masschallenge.org/programs/texas/. Accessed 1 June 2026.
Dell Medical School. "Hongfang Liu Joins Dell Medical School to Lead New Department, Serve as Chief Translational AI and Informatics Officer." Dell Medical School News, University of Texas at Austin, 18 May 2026, dellmed.utexas.edu/news/hongfang-liu-joins-dell-medical-school-to-lead-new-department-of-quantitative-and-systems-health-sciences-serve-as-chief-translational-ai-and-informatics-officer. Accessed 1 June 2026.
Martinez, Alejandra. "Texas County Pauses Data Center Construction in Rural Areas for a Year." The Texas Tribune, 12 May 2026, www.texastribune.org/2026/05/12/texas-hill-county-approves-data-center-construction-pause-ai/. Accessed 1 June 2026.
Shelley, Adrian. "Data Center Developer Uses Courts to Bully Hill County." Public Citizen, 28 May 2026, www.citizen.org/news/data-center-developer-uses-courts-to-bully-hill-county/. Accessed 1 June 2026.
Disclaimer: The Givens Health Venture Report is for informational purposes only and does not constitute financial, legal, or investment advice. The views, data, and analysis expressed in this report are entirely independent and not affiliated with, endorsed by, or representative of any of the venture capital firms, corporate entities, state agencies, or healthcare institutions mentioned herein. Past performance or deal trajectory is not indicative of future market results.
